Zepbound 15 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9BLD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,387
Award facts
- Contract value 100% obligated
- $10,387.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $10,387.25 delivery order to AmerisourceBergen Drug Corp for Zepbound 15 mg/0.5 mL pen injections on December 15, 2025. This firm fixed-price delivery order, which has no set-aside designation, will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 16, 2025. The contract represents a child award under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order for the diabetes medication Zepbound exemplifies the company's extensive portfolio of pharmaceutical product deliveries under the DLA Medical Supply Chain, which encompasses a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The competitively awarded contract underscores AmerisourceBergen's capability to meet federal procurement requirements and its role in supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F9BLD?
SPE2DR26F9BLD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 15, 2025.
How much is contract SPE2DR26F9BLD worth?
The government has obligated $10,387 on SPE2DR26F9BLD.
Is contract SPE2DR26F9BLD an order under another contract?
Yes. SPE2DR26F9BLD is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F9BLD competed?
The extent of competition for SPE2DR26F9BLD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award